Each month, GHEA aggregates the latest news and research related to place-based cancer control and geographic health disparities. Below you will find the latest posts, updated regularly throughout the month.
(Last updated: June 20, 2023)
General Cancer Control News and Research
- A recent study found that extensive continued care and support from family, friends and trusted medical staff is important to the psychological health and social adaptation in postoperative patients with oral cancer.
- According to a recent study, the murine double minute 2 (MDM2) gene is a reliable prognostic biomarker and closely related to cancer immunity. This has led researchers to believe MDM2 inhibitors could enhance the immunotherapeutic effect against breast, bladder and ovarian cancers.
- A recent study revealed that community champions play a crucial role in the uptake of preventative care, specifically cervical screening and HPV self-sampling, among communities with a high prevalence of under-screening.
- According to a recent trial, a new immunotherapy drug named pembrolizumab (KEYTRUDA) has been shown to slow cancer progression and reoccurrence and decrease the presence of residual tumors among lung cancer patients when used in conjunction with neoadjuvant chemotherapy.
- According to a recent study, the European Societies for Medical Oncology and the European Association have designed a hematological specific Magnitude of Clinical Benefit scale to accurately predict the benefit of novel treatments for cancers of the blood.
- Recent studies showed that one dose of the quadrivalent HPV vaccine remains 81% effective against the two most common strains of HPV for up to 18 years.
